Ayurvedic formulations ameliorate cisplatin-induced nephrotoxicity: preclinical studies on Brahma Rasayana and Chyavanaprash

J Cancer Res Ther. 2013 Apr-Jun;9(2):230-4. doi: 10.4103/0973-1482.113363.

Abstract

Aim of study: To explore the ability of two Ayurvedic formulations, Brahma Rasayana (BRM) and Chyavanaprash (CHM) in alleviating Cisplatin (Cis-dichlorodiammineplatinum [II] CDDP) induced acute nephrotoxicity.

Materials and methods: Swiss albino mice were administered with CDDP (12 mg/kg, i.p) and two doses of BRM or CHM (1 and 2 g/kg). Various antioxidant parameters in the kidney as well as release of marker enzymes in the serum were assayed. Histology of the kidney was also performed to check for CDDP induced damages.

Results: Administration of either BRM or CHM (1 and 2 g/kg) maintained the antioxidant status in the kidney thereby preventing tissue damage as well as the release of marker enzymes. CDDP induced variation of renal architecture was also prevented by BRM and CHM administration.

Conclusion: BRM and CHM administration could prevent CDDP induced acute renal toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Chemistry, Pharmaceutical
  • Cisplatin / toxicity*
  • Drug Evaluation, Preclinical
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / drug therapy
  • Kidney Diseases / metabolism
  • Kidney Diseases / prevention & control*
  • Lipid Peroxidation / drug effects
  • Mice
  • Plant Extracts / pharmacology*
  • Plant Preparations / pharmacology*
  • Random Allocation

Substances

  • Antioxidants
  • Chyavanprash
  • Plant Extracts
  • Plant Preparations
  • brahma rasayana
  • Cisplatin